Last reviewed · How we verify
NCT05254977
Post Vaccination Adverse Events in Covid-19 Vaccine Recipients
trial testing Standard Preparation in COVID-19 Vaccination in 3,515 participants. Completed in 30 March 2022.
10 March 2022
Quick facts
| Lead sponsor | Islamia University of Bahawalpur |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 3,515 |
| Start date | 26 February 2022 |
| Primary completion | 10 March 2022 |
| Estimated completion | 30 March 2022 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Standard Preparation — full drug profile →
Conditions studied
- COVID-19 Vaccination — all drugs for COVID-19 Vaccination →
- Vaccine Adverse Reaction — all drugs for Vaccine Adverse Reaction →
Sponsor
Islamia University of Bahawalpur
Who can join
12 and older, any sex, with COVID-19 Vaccination or Vaccine Adverse Reaction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Covid-19 pandemic is caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-Cov-2) since its outbreak 2019. Protection against Covid-19 can be achieved through global immunization. Various vaccines for SARS-Cov-2 has been registered and approved for administration in humans. It is important to understand the safety and efficacy of vaccines during robust research to develop global immunity against SARS-Cov-2. This study aimed to collect data on post vaccination adverse events in regional population of District Bahawalpur.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05254977
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Standard Preparation
Trials testing the same drug.
- NCT05982197 — Curcumin Gel On Radiation Induced Oral Mucositis · NA · completed
- NCT04265105 — Fluticasone-Vilanterol Once Daily Dose for the Treatment of Mild Asthma in Adults · Phase 2, PHASE3 · completed
- NCT05136625 — Sphenopalatine Ganglion Block and Pain Management in Neurosurgery · NA · unknown
- NCT05417529 — Preoperative Music Listening in Odontostomatological Surgery (PMLOS) · NA · completed
- NCT03428724 — Individualized Bowel Preparation for Colonoscopy · Phase 4 · unknown
Other recruiting trials for COVID-19 Vaccination
Currently open trials in the same condition.
- NCT06923137 — A Study to Learn About How Well Yearly Updates to the COVID-19 Vaccine Work to Protect People From COVID-19 and How Much · active not recruiting
- NCT06613984 — Korean Post Marketing Surveillance for Comirnaty Injection (Bretovameran) · active not recruiting
- NCT06156254 — Community Care Intervention to Decrease COVID-19 Vaccination Inequities · NA · recruiting
- NCT04967807 — Myocardial Injury and Outcomes Following COVID-19 Vaccination (MYOVAX Study) · NA · active not recruiting
- NCT04980560 — Gut Microbiota Profile and Its Impact on Immunity Status in COVID-19 Vaccinated Cohorts · active not recruiting
Other Islamia University of Bahawalpur trials
Trials by the same sponsor.
- NCT07042555 — Efficacy of Cognitive Behavior Therapy for Treatment of Chronic Pelvic Pain in Women · NA · not yet recruiting
- NCT06445790 — Efficacy of Cognitive Behavior Therapy in the Treatment of Chronic Pelvic Pain in Women · NA · not yet recruiting
- NCT06562764 — To Evaluate Newly Developed Pictogram Cards and Their Utility in Improving Inhaler Techniques in Asthmatic Patients · NA · active not recruiting
- NCT05692752 — Expression of microRNA-133a and microRNA-208b in Acute Myocardial Infarction · completed
- NCT06123078 — Impact of Schemas, Cognitive Emotion Regulation on Quality of Life of HIV Patients: Assessing Outcomes of CBT · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05254977 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Islamia University of Bahawalpur
- Last refreshed: 13 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05254977.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing